Russia and China launch new pharmaceutical production
A Russian pharmaceutical company has signed an agreement with Chinese partners to establish a new enterprise. The project is aimed at the production of pharmaceutical substances, which are necessary for the manufacturing of medicinal drugs.
The total investment in this project will amount to 13.06 billion tenge. The parties have already agreed on the key stages of cooperation and the distribution of tasks. It is expected that the new production facility will help strengthen technological sovereignty in the medical sector.
The construction of the plant will allow for the establishment of the production of important components within the country. This will significantly reduce dependence on imported raw materials and provide Russian pharmaceutical companies with the necessary materials for creating high-quality medicines.
The implementation of this project is an important step in the development of international cooperation between Russia and China. Experts note that the partnership in the fields of high technology and medicine will contribute to strengthening the economies of both countries.
In the near future, the parties will begin the design of the plant and the procurement of the necessary equipment. The launch of production is planned as part of a long-term strategy for the development of the pharmaceutical industry.